PMC Isochem

PMC Isochem, acquired by PMC International in 2017, is a CDMO manufacturing cGMP intermediates, APIs, and functional excipients for global pharmaceutical and personal care companies. It offers research, development, pilot and industrial production, and regulatory support, with US FDA-audited facilities within 60 miles of Paris. PMC Isochem drives innovation and adds value to clients' intellectual property throughout the product lifecycle. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.